 |
인쇄하기
취소
|
Korea recalls Sanofi Aventis' enoxaparin after OSCS contamination
The Korea Food and Drug Administration has recently recalled one batch of the anticoagulant medicine Clexane (enoxaparin) which has been found to contain the contaminant over-sulphated chondroitin sulphate (OSCS).
The KFDA has been informed by the supplier of Clexane, Sanofi-Aventis Korea, that this recall applies to one batch of Clexane, with batch number 7582. The t
Patients who use Cl...
The KFDA has been informed by the supplier of Clexane, Sanofi-Aventis Korea, that this recall applies to one batch of Clexane, with batch number 7582. The t
Patients who use Cl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.